Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Imaging of Hematologic and Oncologic Disorders
Sphingosine 1-Phosphate: A New Target for Early Diabetic Retinopathy
The role of innate immune evasion in hepatitis C virus infection
Reinforcement and Intrinsic Motivation in Adhd Treatment
Cyclic Nucleotides in Cone Metabolism and Disease
Recently added grants:
Genetic Strategies for Neurodevelopmental Research
Communicating narrative Concerns entered by RNs (CONCERN)
Fluctuations in Ionic Current through Membrane Channels
Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis
A Mass Spectrometry Approach to the Genetic and Epigenetic Mechanisms Controlling Neuronal Identity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67184-3-0-1
Application #
7574882
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hosp Pittsburgh/Upmc Health Sys
$182,089
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Lakshmanan, Krishnamurti /
$236,644
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant